Journal issues > Issue 4, August 2018 > Recent advances in the treatment of acute leukemia

Recent advances in the treatment of acute leukemia

SUMMARY

The treatment modalities in the field of acute leukemia have seen spectacular changes in recent years. The introduction of chimeric antigen receptor T-cells (CAR T-cells) and bispecific T-cell engagers (BiTEs) dramatically improved the outcome of heavily pretreated patients with B-cell acute lymphoblastic leukemia (B-ALL). For the treatment of acute myeloid leukemia (AML), immunotherapy is more difficult to design, but also in this setting progress has been made. This text will describe recent advances in the field of acute leukemia presented at the latest EHA meeting.

(BELG J HEMATOL 2018;9(4):148–51)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €2.42

** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top